The Microarray Facility now offers:

The world's first pharmacogenomic microarray designed for clinical applications.
The AmpliChip CYP450 Test is powered by Affymetrix technology. It provides comprehensive coverage of gene variations – including deletions and duplications – for the 2D6 and 2C19 genes, which play a role in the metabolism of about 25% of all prescription drugs. It is intended to be an aid for physicians in individualizing treatment doses for patients on therapeutics metabolized through these proteins. For further information please contact us.